Nestle Health Science US Holdings Inc. 13D/13G Filings for AIMMUNE THERAPEUTICS INC (AIMT)

Nestle Health Science US Holdings Inc. 13D and 13G filings for AIMMUNE THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView